![](http://cdn.i.haymarketmedia.asia/?n=finance-asia%2fcontent%2fshutterstock_1074856703.jpg&h=410&w=728&q=75&v=cc2c1ec47c&c=1)
CBC Group buys UCB's China mature neurology and allergy arm
The $680m deal includes UCB's brands Keppra, Vimpat, Neupro, Zyrtec, Xyzal, and its Zhuhai manufacturing site, and was made in partnership with Mubadala Investment Co.
December 03, 2024